Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate In The Superficial Varicose Veins Treatment

PHASE III OF SAFETY AND EFFICACY STUDY OF TOPIC MUCOPOLYSACCHARIDE POLYSULFATE 5MG/G IN THE SUPERFICIAL VARICOSE VEINS TREATMENT

Evaluate the safety, tolerability and effectiveness of mucopolysaccharide polysulfate in the treatment of superficial varicose veins

Inclusion Criteria:

• Patients must be able to understand the study procedures, agree to participate, and give written consent.
• Patients must be able to follow the study medication regimen.
• Patients with inflammatory process in superficial veins for more than 72 hours.
• Presence of symmetric lesions to compare one side to the other.

Exclusion Criteria:

• Pregnancy or risk of pregnancy.
• Lactation.
• Use of topical or systemic anti-inflammatory, antihistamine or immunosuppressive drugs within the last 48 hours prior to the study
• Any alteration at other deep veins.
• History of atopy or allergic diseases.
• History of allergy to any component of the formulations.
• Other conditions considered by the investigator as reasonable for non-eligibility.